{
  "Risks Related to Our Business and Our Industry": [
    "COVID-19 pandemic impact",
    "Cost reduction challenges",
    "IT system failures",
    "Cybersecurity breach",
    "Intense competition",
    "Third-party dependency",
    "Legal proceedings exposure",
    "Acquisition integration risks",
    "Key personnel dependency",
    "Economic conditions impact",
    "Workforce retention challenges",
    "Investment portfolio fluctuations",
    "new factor: Intangible asset impairment risk",
    "new factor: Proprietary rights risk",
    "Credit rating downgrade risk"
  ],
  "Risks Related to the Regulation of Our Business": [
    "Regulatory compliance failure",
    "Government program funding risk",
    "Pharmacy regulatory risks",
    "Privacy law compliance",
    "Capital restriction risk"
  ]
}